Moreover, it has been shown that low-dose DEHP induces an unbalanced E2/T ratio and increased COX-2 and L-PGDS expressions that might be responsible for developing prostatic hyperplasia [52]. The gene discussed is PTGDS; the disease is benign prostatic hyperplasia.